- Home
- MYFW vs CDXS Comparison
MYFW vs CDXS Comparison
Compare MYFW & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MYFW | CDXS |
|---|---|---|
| Founded | 2002 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 256.7M | 256.3M |
| IPO Year | 2018 | 2008 |
Fundamental Metrics
Financial Performance| Metric | MYFW | CDXS |
|---|---|---|
| Price | $29.44 | $2.61 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $27.00 | N/A |
| AVG Volume (30 Days) | 28.3K | ★ 824.4K |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.02 | 43.82 |
| EPS | ★ 0.63 | N/A |
| Revenue | $96,914,000.00 | ★ $138,590,000.00 |
| Revenue This Year | $20.48 | $7.73 |
| Revenue Next Year | $9.70 | $14.24 |
| P/E Ratio | $46.32 | ★ N/A |
| Revenue Growth | 7.60 | ★ 32.30 |
| 52 Week Low | $20.29 | $0.96 |
| 52 Week High | $30.00 | $3.87 |
Technical Indicators
Market Signals| Indicator | MYFW | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 60.64 | 50.41 |
| Support Level | $22.04 | $2.39 |
| Resistance Level | $30.00 | $2.87 |
| Average True Range (ATR) | 0.82 | 0.15 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 73.97 | 44.14 |
Price Performance
Historical ComparisonAbout MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
About CDXS Codexis Inc.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.